Related Experiment Video
Updated: Feb 23, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with
Insights
Cystatin C levels effectively predict cardiovascular mortality in patients with suspected acute coronary syndromes (ACS). This renal function marker offers earlier detection of risk compared to serum creatinine, aiding in patient management.
Area of Science:
- Nephrology
- Cardiology
- Biomarkers
Background:
- Serum cystatin C increases early in chronic kidney disease (CKD), even before serum creatinine levels rise.
- Patients with CKD have a higher risk of cardiovascular disease (CVD) and related premature death.
- Serum creatinine levels can decrease with age, potentially masking underlying kidney issues.
Purpose of the Study:
- To evaluate cystatin C, serum creatinine, and estimated glomerular filtration rate (eGFR) as predictors of cardiovascular mortality.
- To assess these markers in patients presenting to the emergency department (ED) with suspected acute coronary syndromes (ACS).
Main Methods:
- A prospective study involving 1,282 patients with suspected ACS.
- Baseline measurements of cystatin C, serum creatinine, and eGFR were taken in the ED.
- Clinical assessment and cardiac troponin T measurements were used for ACS diagnosis; cardiovascular deaths were tracked over 365 days.
Main Results:
- Univariate analysis showed significant associations for cystatin C (HR 12.02), serum creatinine (HR 4.53), and eGFR (HR 0.97) with cardiovascular mortality.
- In a multivariate model including all three markers, cystatin C (HR 59.21) and serum creatinine (HR 0.08) remained significant predictors.
- The risk association was significant for natural logarithms of cystatin C and serum creatinine.
Conclusions:
- Quantifying renal function using cystatin C is valuable for predicting cardiovascular mortality in patients with suspected ACS.
- Cystatin C serves as an important biomarker for cardiovascular risk assessment in the ED setting.
Background:
Increases in the novel serum marker cystatin C are detectable much earlier in the course of chronic kidney disease (CKD) even when levels of serum creatinine are still in the normal range. A major factor causing a decrease in serum creatinine is increasing age. Patients with CKD are more likely to develop cardiovascular disease (CVD) than a healthy population and to suffer premature deaths from CVD related to CKD. The aim of this study was to investigate whether cystatin C, serum creatinine, and estimated glomerular filtration rate (eGFR) predict cardiovascular mortality in patients admitted to the emergency department (ED) with suspected acute coronary syndromes (ACS).
Methods:
In 1,282 patients (mean age 62 ± 15 years, 477 women, 805 men) with suspected ACS, baseline cystatin C concentrations, serum creatinine, and estimated glomerular filtration rate (eGFR) were measured at the ED. Clinical assessment and serial high sensitivity cardiac troponin T (hs-cTnT) measurements were used for the diagnosis of ACS. Seventeen cardiovascular deaths were registered during a median follow-up of 365 days.
Results:
HRs from univariate Cox regression models for each of the potential biomarkers were 12.02 (95% CI 5.10 - 28.34) for cystatin C, 4.53 (1.75 - 11.70) for serum creatinine, and 0.97 (0.96 - 0.99) for eGFR. All three biomarkers showed a significant association with cardiovascular mortality in univariate analyses. The HRs from a model with all three potential biomarkers were 59.21 (95% CI 9.69 - 361.76) for cystatin C, 0.08 (0.01 - 0.58) for serum creatinine, and 0.98 (0.96 - 1.01) for eGFR. The risk association was significant for ln (cystatin C) and ln (serum creatinine).
Conclusions:
Results of this prospective study show that the quantification of renal function using cystatin C is useful for predicting cardiovascular mortality in patients with suspected ACS at the ED.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Acute Kidney Injury I: Introduction

